CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Dec 02, 2024. (Total: 6432 publications)

All Cancer Diabetes Economic Equity Environmental FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search Year Journal

Records 1-5 (of 5 Records)

Query Trace: Dalton TL[original query]
Use of Nucleic Acid Amplification Testing for Rapid Detection of Mycobacterium tuberculosis Complex Among US Tuberculosis Patients, 2011‒2017. Kumar V , Dalton TL , Armstrong LR , Whitesell A , Li R , Starks AM . Open Forum Infect Dis 2021 8 (11) ofab528
Molecular evaluation of fluoroquinolone resistance in serial Mycobacterium tuberculosis isolates from individuals diagnosed with multidrug-resistant tuberculosis. Willby M , Chopra P , Lemmer D , Klein K , Dalton TL , Engelthaler DM , Cegielski P , Posey JE . Antimicrob Agents Chemother 2020 65 (1)
Isoniazid- and Rifampin-Resistance Mutations Associated with Resistance to Second-line Drugs and with Sputum Culture Conversion. Click ES , Kurbatova E , Alexander H , Dalton TL , Chen MP , Posey JE , Ershova JJ , Cegielski P . J Infect Dis 2020 221 (12) 2072-2082
Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests. Kandler JL , Mercante AD , Dalton TL , Ezewudo MN , Cowan LS , Burns SP , Metchock B , Cegielski P , Posey JE . Antimicrob Agents Chemother 2018 62 (10)
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Campbell PJ , Morlock GP , Sikes RD , Dalton TL , Metchock B , Starks AM , Hooks DP , Cowan LS , Plikaytis BB , Posey JE . Antimicrob Agents Chemother 2011 55 (5) 2032-41